Use of chemotherapy, race and differences in employment support — including paid sick leave and flexible working schedules — all had an impact on whether women lost more than a month of work or stopped working entirely after treatment. (sciencedaily.com)
The use of CPX - 351 reduced the risk of death by 31 % compared to the use of the chemotherapy drugs cytarabine and daunorubicin. (sciencedaily.com)
Progress in prevention and early detection, and the use of chemotherapy after surgery (adjuvant chemotherapy), have achieved significantly increase survival in this disease in the last ten years, but much remains to be done. (sciencedaily.com)